FDA commissioner speculation focusing more sharply on U. of New Mexico's Henney.
This article was originally published in The Rose Sheet
Executive Summary
FDA COMMISSIONER-APPARENT HENNEY WOULD FACE CONTINUED LIMITED RESOURCES for all agency activities, including cosmetics regulation and oversight of increasingly drug-oriented claims for cosmetics products. With the delay in the appointment of a permanent successor to FDA Commissioner David Kessler, MD, the restless audience of Washington FDA watchers has begun to speculate on a sequel appearance for ex-agency official Jane Henney, MD.